Detalles de la búsqueda
1.
A phase II open-label trial of bortezomib in patients with multiple myeloma who have undergone an autologous peripheral blood stem cell transplant and failed to achieve a complete response.
Invest New Drugs
; 30(2): 714-22, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20938715
2.
Randomized phase II study of cetuximab and bevacizumab in combination with two regimens of paclitaxel and carboplatin in chemonaive patients with stage IIIB/IV non-small-cell lung cancer.
J Thorac Oncol
; 8(3): 338-45, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23370316
3.
A randomized, multicenter, open-label comparison of the antiemetic efficacy of dolasetron versus ondansetron for the prevention of nausea and vomiting during high-dose myeloablative chemotherapy.
Support Cancer Ther
; 2(2): 114-21, 2005 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18628198
4.
Impaired gastric slow wave rhythmicity in patients after bone marrow or stem cell transplant.
Dig Dis Sci
; 47(8): 1746-51, 2002 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12184525
Resultados
1 -
4
de 4
1
Próxima >
>>